Skip to content
Screener

Mirion Technologies MIR Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.06B-11.7%
FactSet Research Systems logo
FactSet Research SystemsFDS
$294.41M-20.5%
Nano Nuclear Energy logo
Nano Nuclear EnergyNNE
$197.68M+66.7%
BWX Technologies logo
BWX TechnologiesBWXT
$520.33M+740%
Novanta logo
NovantaNOVT
$718.65M+554%
NuScale Power logo
NuScale PowerSMR
$346.23M-30.3%

Segments

By segment

See full
Nuclear & Safety$4.6M

Other financials

Income statement

See full
Revenue$266.8M+19.7%
Gross profit$133.1M+29.9%
Operating income$17.9M+80.8%
Net income$7.7M-7.2%
EPS (diluted)$0.030.0%

Balance sheet

See full
Total debt$476.6M-0.1%
Total equity$1.8B+24.9%
Total assets$3.5B+28.6%

Cash flow

See full
Operating cash flow$58.5M+372%
CapEx$10.4M+18.2%
Free cash flow$48.1M+1,236%

Valuation

See full
Market cap$3.74B-24.7%
Enterprise value$3.8B-26.7%
P/E152.7×
P/S3.7×-2.0×

Profitability

See full
Gross margin48%+1.3pp
Operating margin5.3%+0.1pp
Net margin2.4%
FCF margin13%+3.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.1×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Mirion Technologies’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050604
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Financing costs(3.1)
Proceeds from cash flow hedge derivative contracts0.10.2
Other financing0.6(0.4)
Net cash (used in) provided by financing activities(45.2)41.2
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(6.0)13.9
Net increase (decrease) in cash, cash equivalents, and restricted cash6.487.4
Cash, cash equivalents, and restricted cash at beginning of period415.2175.6
Cash, cash equivalents, and restricted cash at end of period$421.6$263.0

Item 1. Financial Statements (Unaudited)

FAQ

What is Mirion Technologies's cash & equivalents?
Mirion Technologies (MIR) reported cash & equivalents of $421.6M in Q2 2026.
How has Mirion Technologies's cash & equivalents changed year-over-year?
Mirion Technologies's cash & equivalents increased by 60.3% year-over-year, from $263M to $421.6M.
What is the long-term trend for Mirion Technologies's cash & equivalents?
Over 5 years (2020 to 2025), Mirion Technologies's cash & equivalents has grown at a 304.5% compound annual growth rate (CAGR), from $383.25K to $415.2M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Mirion Technologies's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude